Mitochondrial Artificial K+ Channel Construction Using MPTPP@5F8 Nanoparticles for Overcoming Cancer Drug Resistance via Disrupting Cellular Ion Homeostasis
Panqin Ma,Zheng Luo,Zhiguo Li,Yuchao Lin,Zibiao Li,Zhen Wu,Changliang Ren,Yun‐Long Wu
DOI: https://doi.org/10.1002/adhm.202302012
IF: 10
2023-09-25
Advanced Healthcare Materials
Abstract:Mitochondrial potassium ion channels have become a promising target for cancer therapy. However, in malignant tumours, their low expression or inhibitory regulation typically leads to undesired cancer therapy, or even induces drug resistance. Herein, we developed an in situ mitochondria‐targeted artificial K+ channel construction strategy, with the purpose to trigger cancer cell apoptosis by impairing mitochondrial ion homeostasis. By considering the fact that cancer cells have a lower membrane potential than that of normal cells, our strategy could selectively deliver artificial K+ channel molecule 5F8 to the mitochondria of cancer cells, by using a mitochondria‐targeting triphenylphosphine modified block polymer (MPTPP) as a carrier. More importantly, 5F8 could further specifically form a K+‐selective ion channel through the directional assembly of crown ethers on the mitochondrial membrane, thereby inducing mitochondrial K+ influx and disrupting ions homeostasis. Thanks to this design, mitochondrial dysfunction, including decreased mitochondrial membrane potential, reduced ATP synthesis, downregulated anti‐apoptotic BCL‐2 and MCL‐1 protein levels, and increased ROS levels, could further effectively induce the programmed apoptosis of multidrug‐resistant cancer cells, no matter in case of pump or non‐pump dependent drug resistance. In short, this mitochondria‐targeted artificial K+‐selective ion channel construction strategy might be beneficial for potential drug resistance cancer therapy. This article is protected by copyright. All rights reserved
nanoscience & nanotechnology,engineering, biomedical,materials science, biomaterials